MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, VIR has $1,019,453K in assets. $223,355K in debts. $170,084K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
725.43%
Cash Ratio
226.11%
Debt to Asset Ratio
21.91%
Assets Breakdown
    • Short-term investments
    • Long-term investments
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liabilities, non...
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
170,084 211,104
Short-term investments
327,750 387,645
Restricted cash and cash equivalents, current
2,215 88,218
Equity investments
8,679 7,270
Prepaid expenses and other current assets
36,956 41,469
Total current assets
545,684 735,706
Intangible assets, net
7,924 7,998
Goodwill
16,937 16,937
Property and equipment, net
58,203 60,795
Operating lease right-of-use assets
63,555 64,853
Restricted cash and cash equivalents, noncurrent
6,957 6,956
Long-term investments
304,212 286,099
Other assets
15,981 13,188
Total assets
1,019,453 1,192,532
Accounts payable
6,847 12,234
Accrued and other liabilities
68,375 82,661
Deferred revenue, current
0 10,109
Contingent consideration obligation, current
0 0
Total current liabilities
75,222 105,004
Deferred revenue, noncurrent
9,433 -
Operating lease liabilities, noncurrent
91,215 93,405
Contingent consideration obligation, noncurrent
34,180 33,620
Other long-term liabilities
13,305 13,031
Total liabilities
223,355 245,060
Common stock, 0.0001 par value 300,000,000 shares authorized as of september30, 2025 and december31, 2024 139,022,594 and 136,959,446 shares issued and outstanding as of september30, 2025 and december31, 2024, respectively
14 14
Additional paid-in capital
1,952,843 1,941,386
Accumulated other comprehensive loss
-1,911 -2,221
Accumulated deficit
-1,154,848 -991,707
Total stockholders equity
796,098 947,472
Total liabilities and stockholders equity
1,019,453 1,192,532
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Prepaid expenses andother current assets$36,956K Equity investments$8,679K Restricted cash and cashequivalents, current$2,215K Short-term investments$327,750K Cash and cashequivalents$170,084K Other assets$15,981K Long-term investments$304,212K Restricted cash and cashequivalents, noncurrent$6,957K Operating leaseright-of-use assets$63,555K Property and equipment,net$58,203K Goodwill$16,937K Intangible assets, net$7,924K Total current assets$545,684K Total assets$1,019,453K Total liabilities andstockholders equity$1,019,453K Total stockholdersequity$796,098K Total liabilities$223,355K Accumulated deficit-$1,154,848K Accumulated othercomprehensive loss-$1,911K Additional paid-in capital$1,952,843K Other long-termliabilities$13,305K Contingent considerationobligation, noncurrent$34,180K Operating leaseliabilities, noncurrent$91,215K Deferred revenue,noncurrent$9,433K Total currentliabilities$75,222K Common stock, 0.0001par value...$14K Accrued and otherliabilities$68,375K Accounts payable$6,847K

Vir Biotechnology, Inc. (VIR)

Vir Biotechnology, Inc. (VIR)